Suppr超能文献

通过抑制传统韩方枳术茯苓丸的COX-1活性抑制人肝癌细胞中的肿瘤起始

Tumor initiation inhibition through inhibition COX-1 activity of a traditional Korean herbal prescription, Geiji-Bokryung-Hwan, in human hepatocarcinoma cells.

作者信息

Park Won-Hwan, Lee Soo-Kyung, Oh Hoon-Kyu, Bae Jong-Yub, Kim Cheorl-Ho

机构信息

Department of Biochemistry, Molecular Biology and Diagnostics, Dongguk University College of Oriental Medicine and National Research Laboratory for Glycobiology, Kyungju, Kyungbuk, South Korea.

出版信息

Immunopharmacol Immunotoxicol. 2005;27(3):473-83. doi: 10.1080/08923970500241311.

Abstract

Some Korean and oriental herbal prescriptions used for a syndrome expressed as chest paralysis and heartache are thought to be effective for angina pectoris. We investigated the effects of an oriental medicinal prescription, Geiji-Bokryung-Hwan (GBH) consisting of herbs of Cinnamomi Ramulus, Poria Cocos Hoelen (Pachymae Fungus), Moutan Cortex Radicis, Paeoniae Radix, and Persicae Semen, on growth-inhibitory activity and cancer chemopreventive activity in assays representing three major stages of carcinogenesis. The GBH was found to act as an potent inhibitor of cyclooxygenase (COX)-1 only but not as COX-2 inhibitor. Furthermore, the extract mediated anti-inflammatory effects and inhibited COX-associated hydroperoxidase functions (anti-promotion activity). Inhibitory effect of the GBH on the growth of cancer cell lines such as HepG2 cell and Hep3B cell was shown. These data suggest that GBH extracts merit investigation as a potential cancer chemopreventive agent in humans, especially in hepatological cancers.

摘要

一些用于治疗表现为胸部痹痛和心痛综合征的韩国及东方草药方剂被认为对心绞痛有效。我们研究了一种由桂枝、茯苓(茯神)、牡丹皮、芍药和桃仁组成的东方药方剂——枳术茯苓丸(GBH)在代表致癌三个主要阶段的实验中对生长抑制活性和癌症化学预防活性的影响。结果发现GBH仅作为一种有效的环氧化酶(COX)-1抑制剂,而不是COX-2抑制剂。此外,该提取物介导了抗炎作用并抑制了COX相关的氢过氧化物酶功能(抗促癌活性)。GBH对肝癌细胞系如HepG2细胞和Hep3B细胞的生长具有抑制作用。这些数据表明,GBH提取物值得作为一种潜在的人类癌症化学预防剂进行研究,尤其是在肝癌方面。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验